메뉴 건너뛰기




Volumn 24, Issue 7, 2001, Pages 492-499

A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease

Author keywords

Antithrombotic therapy; Low molecular weight heparin; Non ST segment elevation myocardial infarction; Unstable angina

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

EID: 0034950768     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240715     Document Type: Article
Times cited : (6)

References (31)
  • 6
    • 0025090942 scopus 로고
    • Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
    • (1990) Lancet , vol.336 , pp. 827-830
  • 9
    • 0032514663 scopus 로고    scopus 로고
    • Low-molecular-weight heparin. A review of the results of recent studies of the treatment of venous thromboembolism and unstable angina
    • (1998) Circulation , vol.98 , Issue.15 , pp. 1575-1582
    • Hirsh, J.1
  • 11
    • 9044243412 scopus 로고    scopus 로고
    • Low-molecular-weight heparin during instability in coronary artery disease
    • (1996) Lancet , vol.347 , pp. 561-568
  • 14
    • 0032742229 scopus 로고    scopus 로고
    • Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q-wave myocardial infarction: FRAX.I.S. (FRAXiparine in Ischaemic Syndrome)
    • (1999) Eur Heart J , vol.20 , pp. 1553-1562
  • 16
    • 0033612951 scopus 로고    scopus 로고
    • Invasive compared with noninvasive treatment in unstable coronary artery disease. FRISC II prospective randomised multicentre study
    • FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators
    • (1999) Lancet , vol.354 , pp. 708-715
  • 17
    • 0033612915 scopus 로고    scopus 로고
    • Long-term low molecular mass heparin in unstable coronary artery disease. FRISC II prospective randomised multicentre study
    • (1999) Lancet , vol.354 , pp. 701-707
  • 18
    • 0030992622 scopus 로고    scopus 로고
    • Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI 11A
    • (1997) J Am Coll Cardiol , vol.29 , pp. 1474-1482
  • 20
    • 0034042313 scopus 로고    scopus 로고
    • Low molecular weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin?
    • (2000) J Am Coll Cardiol , vol.35 , pp. 1699-1712
    • Kaul, S.1    Shah, P.K.2
  • 22
    • 0030762734 scopus 로고    scopus 로고
    • A low molecular weight, selective thrombin inhibitor, inogatran, vs. Heparin, in unstable coronary artery disease in 1206 patients
    • (1997) Eur Heart J , vol.18 , pp. 1416-1424
  • 25
    • 0031032540 scopus 로고    scopus 로고
    • Troponin T identifies patients with unstable coronary artery disease, who benefit from long-term antithrombotic protection
    • Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group
    • (1997) J Am Coll Cardiol , vol.29 , pp. 43-48
    • Lindahl, B.1    Venge, P.2    Wallentin, L.3
  • 31
    • 0004661135 scopus 로고    scopus 로고
    • GUSTO IV ACS (Global Utilisation of Streptokinase and t-PA for Occluded coronary arteries trial IV in ACS): Substudy comparing outcomes for the combination of abciximab with standard UFH or LMWH
    • Presented during the XXII Congress of the European Society of Cardiology, August 26-30, 2000, Amsterdam, The Netherlands
    • (2000) Hotline
    • Wallentin, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.